TUESDAY, Oct. 23 (HealthDay News) -- Drug company-funded studies of asthma drugs called inhaled corticosteroids are less likely to find adverse effects than studies that were paid for by other sources, Spanish researchers say.A team from Children’s Hospital La Fe in Valencia analyzed 504 studies of the drugs conducted between 1993 and 2002.
